Evidence map›Paper›PMID 34038127›Full record

ArticleJournal of the American Chemical Society2021

Visualizing the Dynamic Metalation State of New Delhi Metallo-β-lactamase-1 in Bacteria Using a Reversible Fluorescent Probe.

Radhika Mehta, Dann D Rivera, David J Reilley, Dominique Tan, Pei W Thomas, Abigail Hinojosa, Alesha C Stewart, Zishuo Cheng, Caitlyn A Thomas, Michael W Crowder and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Proteomic strategies to interrogate the Fe-S proteome.Biochimica et biophysica acta. Molecular cell research · 2024
    Review
  2. Review
  3. Article
  4. Metalloprotein enabled redox signal transduction in microbes.Current opinion in chemical biology · 2023
    Review
  5. Exploring antibiotic resistance with chemical tools.Chemical communications (Cambridge, England) · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Radhika MehtaDepartment of Chemistry, University of Texas at Austin, 105 East 24th Street Stop A5300, Austin, Texas 78712, United States.ORCID 0000-0002-8677-110X
Dann D RiveraDivision of Chemical Biology & Medicinal Chemistry, College of Pharmacy, University of Texas, Austin, Texas 78712, United States.
David J ReilleyDepartment of Chemistry and Biochemistry, University of California-Los Angeles, 607 Charles E. Young Drive, Los Angeles, California 90095-1569, United States.
Dominique TanDepartment of Chemistry, University of Texas at Austin, 105 East 24th Street Stop A5300, Austin, Texas 78712, United States.
Pei W ThomasDivision of Chemical Biology & Medicinal Chemistry, College of Pharmacy, University of Texas, Austin, Texas 78712, United States.
Abigail HinojosaDepartment of Chemistry, University of Texas at Austin, 105 East 24th Street Stop A5300, Austin, Texas 78712, United States.
Alesha C StewartDivision of Chemical Biology & Medicinal Chemistry, College of Pharmacy, University of Texas, Austin, Texas 78712, United States.
Zishuo ChengDepartment of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, United States.
Caitlyn A ThomasDepartment of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, United States.
Michael W CrowderDepartment of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, United States.ORCID 0000-0002-3138-0283
Anastassia N AlexandrovaDepartment of Chemistry and Biochemistry, University of California-Los Angeles, 607 Charles E. Young Drive, Los Angeles, California 90095-1569, United States.ORCID 0000-0002-3003-1911
Walter FastDivision of Chemical Biology & Medicinal Chemistry, College of Pharmacy, University of Texas, Austin, Texas 78712, United States.ORCID 0000-0001-7567-2213
Emily L QueDepartment of Chemistry, University of Texas at Austin, 105 East 24th Street Stop A5300, Austin, Texas 78712, United States.ORCID 0000-0001-6604-3052
The University of Texas at Austin · USMiami University · USUniversity of California, Los Angeles · US

Funding

Targeted molecular strategies for cellular investigation of metalloproteinsR35GM133612 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Emily L Que · 2019 to 2026
$2.8M
Developing Metallo-Beta-Lactamase InhibitorsR01GM111926 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BONOMO, ROBERT A., COHEN, SETH M · 2015 to 2019
$2.3M
Redox enzymes - tuning and designR01GM134047 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEXANDROVA, ANASTASSIA N, YANG, JENNY · 2019 to 2022
$1.3M
Machine Learning Approach for finding novel metallo-b-lactamase inhibitorsR15GM134454 · NIGMS · MIAMI UNIVERSITY OXFORD · PI CROWDER, MICHAEL W · 2019 to 2022
$867k
Bruker AVANCE III HD 500 MHz NMRS10OD021508 · OD · UNIVERSITY OF TEXAS AT AUSTIN · PI SESSLER, JONATHAN L · 2016 to 2016
$529k
NIGMS NIH HHS R01 GM111926NIGMS NIH HHS R01 GM134047NIGMS NIH HHS R15 GM134454NIGMS NIH HHS R35 GM133612NIH HHS S10 OD021508
6 · The paper itself

Abstract

New Delhi metallo-β-lactamase (NDM) grants resistance to a broad spectrum of β-lactam antibiotics, including last-resort carbapenems, and is emerging as a global antibiotic resistance threat. Limited zinc availability adversely impacts the ability of NDM-1 to provide resistance, but a number of clinical variants have emerged that are more resistant to zinc scarcity (e.g., NDM-15). To provide a novel tool to better study metal ion sequestration in host-pathogen interactions, we describe the development of a fluorescent probe that reports on the dynamic metalation state of NDM within

Indexed as

beta-LactamasesChelating AgentsEnzyme InhibitorsEscherichia coliFluorescent DyesMolecular StructureSulfhydryl CompoundsZincbeta-lactamase NDM-1beta-LactamasesChelating AgentsEnzyme InhibitorsFluorescent DyesSulfhydryl CompoundsZinc

Identifiers

PMID34038127
PMCPMC8230704
OpenAlexW3165815693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.